The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Erstveröffentlichung
2018
Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors
Flinn, Ian W.
Hillmen, Peter
Montillo, Marco
Nagy, Zsolt
Illes, Arpad
et al.
Institutions
UKU. Klinik für Innere Medizin III
Published in
Blood ; 132 (2018), 23. - S. 2446-2455. - ISSN 0006-4971. - eISSN 1528-0020
Link to publication
https://dx.doi.org/10.1182/blood-2018-05-850461
Funding information
Verastem Oncology
Infinity Pharmaceuticals Inc.
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record